XML 27 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1

Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2018

Financial Instruments

Schedule of Contingent consideration

		Diabetes
		Alliance		Other		Total		Total
		2018		2018		2018		2017
		$m		$m		$m		$m
At 1 January		4,477		1,057		5,534		5,457
Settlements		(151)		–		(151)		(260)
Revaluations		–		38		38		(71)
Discount unwind		168		40		208		205
At 30 June		4,494		1,135		5,629		5,331

X

- Definition

The disclosure of contingent liabilities in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2017-01-01
-Paragraph B64
-Subparagraph j
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=3&date=2017-03-01&anchor=para_B64_j&doctype=Appendix&seq=2
-URIDate 2017-03-09

+ Details

Name:	ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration